NCT02330003View on ClinicalTrials.gov

Phase 1 Study to Assess the Safety of Inactivated Split Influenza Vaccine and Control Vaccine in Korean Volunteer

PHASE1CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Healthy
Interventions
BIOLOGICAL

IL-YANG FLU Vaccine Prefilled Syringe INJ.

Second vaccination (only for the test group) of IL-YANG FLU Vaccine Prefilled Syringe INJ.0.5mL

BIOLOGICAL

Fluarix Prefilled Syringe

Fluarix Prefilled Syringe 0.5mL

All Listed Sponsors
lead

Il-Yang Pharm. Co., Ltd.

INDUSTRY

NCT02330003 - Phase 1 Study to Assess the Safety of Inactivated Split Influenza Vaccine and Control Vaccine in Korean Volunteer | Biotech Hunter | Biotech Hunter